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Introduction
Cryptorchidism is the most frequent congenital birth
defect in male children and can occur as an isolated dis-
order or in association with other congenital anomalies
(syndromic cryptorchidism) (Toppari et al., 2006). Our
understanding of the physiology of testis descent has
greatly advanced in the last few years (Ivell & Hartung,
2003; Virtanen & Toppari, 2008). It has become evident
that a major role in testis descent is played by two major
hormone ⁄ receptor systems: testosterone and its receptor
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The aetiopathogenesis of isolated cryptorchidism remains largely unknown.
Mutation screenings in the most relevant candidate genes for testicular maldes-
cent lead to controversial data in the literature. In particular, the role of the
T222P genetic variant of the RXFP2 gene is still debated. Given the controver-
sies, the aim of this study was to provide further data on this genetic variant in
two Mediterranean populations. A total of 577 subjects from Spain and 550
from Italy (with and without a history of cryptorchidism) were analysed. The
T222P substitution was found in both unilateral and bilateral cases and in a
total of 12 controls. These data exclude a clear-cut cause–effect relationship
between T222P variant and testicular maldescent. The T222P variant was found
at a similar frequency in both cases and controls in the Spanish population,
whereas in Italy, the frequency of T222P resulted significantly higher in the
cryptorchid group (p = 0.031). The observed difference between the two coun-
tries and the highly variable phenotypic expression of the T222P variant may
depend on the genetic background or on environmental conditions. The haplo-
type analysis of the RXFP2 gene in T222P carriers and their parents showed
that this variant is linked to the previously inferred C-C-G-A-13 haplotype and
consequently provides further support to the ‘founder effect’ hypothesis. In
conclusion, our data indicate that T222P is a frequent variant in the Spanish
population with no pathogenic effect. Although in Italy it seems to confer a
mild risk (odds ratio = 3.17, 95% confidence interval: 1.07–9.34) to cryptorchi-
dism, the screening for this variant for diagnostic purposes is not advised
because of the relatively high frequency of control carriers (1.4% of Italian
men without a history of cryptorchidism).
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LGR8) system, insulin-like factor 3 (INSL3) and its
G-protein-coupled receptor, RXFP2 (relaxin family
peptide 2). INSL3 ⁄RXFP2 are essential for the first phase
of testicular descent, whereas androgens are involved in
the inguinal phase (Foresta et al., 2008). It was pre-
dicted that mutations in genes coding for the two
hormone ⁄ receptor systems should cause cryptorchidism.
Since the first mutation screening of the INSL3 gene in
cryptorchid men (Krausz et al., 2000), a large number of
polymorphisms and putative mutations have been
described (Adham & Agoulnik, 2004; Ferlin et al., 2006).
Of all reported mutations, only two missense mutations,
the P49S and V18M, have a deleterious effect on the
ability of INSL3 to activate its receptor (Bogatcheva
et al., 2003; El Houate et al., 2007). However, the role
of these mutations (all heterozygous) in the pathogenesis
of cryptorchidism remains to be established. Concerning
the RXFP2 gene, only one missense mutation at codon
222 (T222P) has been reported. According to the first
two studies, this mutation was present in heterozygosity
exclusively in men with history of testicular maldescent
(Gorlov et al., 2002; Ferlin et al., 2003). In addition,
functional analysis showed a severely reduced receptor
surface expression of the mutant protein further sup-
porting its causative role in the pathogenesis of cryptor-
chidism (Bogatcheva et al., 2007). However, the
proposed clear-cut cause–effect relationship between het-
erozygous mutation and cryptorchidism has been
recently challenged by a multicentre study, which has
clearly demonstrated that this genetic variant may not
be considered further as a pathogenic mutation as it can
be also found in men with no history of testicular mal-
descent (Nuti et al., 2008). In this study, it was also
demonstrated that the T222P variant is not restricted to
the Mediterranean region, as it was observed also in a
Central European country. Another recent study from
Morocco has also reported a high frequency for this var-
iant in the range of polymorphism in both cryptorchid
men and non-cryptorchid men (El Houate et al., 2008).
Despite these controversies, the T222P variant has been
reported as a genetic alteration associated with persistent
bilateral cryptorchidism in a recent study on newborn
children from Italy (Ferlin et al., 2008).
The role of T222P variant in Spain has not been fully
investigated and only a small study population (77
patients and 48 controls) was screened in a multicentre
study (Nuti et al., 2008). In the aforementioned study,
the frequency of T222P mutation was 0% in the patient
and 4% in the control groups, showing an inverse situa-
tion to that observed in the Italian population in which
5% of patients had the mutation vs. 1.8% of the controls.
Given the controversies in the literature and the appar-
ent sharp contrast between Italy and Spain, we sought to
investigate further into the clinical significance of this
genetic variant in the two Mediterranean populations by
screening a total of 386 cases and 741 controls. Moreover,
we also aimed to clarify the founding mutation issue by
performing the RXFP2 gene haplotype analysis in the
mutation carriers and in their parents.
Materials and methods
Study populations
A total of 577 subjects of Spanish ancestry were analysed
for the T222P variant of RXFP2. Among them, 187
patients had a history of cryptorchidism, whereas the
remaining 390 were controls with no history of testicular
maldescent at birth. The cryptorchid group included 113
with unilateral (1 of them had ‘retractile’ testis), 74 with
bilateral cryptorchidism (6 of them had ‘retractile testis’).
Part of this study population has been already screened in
the multicentre study by Nuti et al. (2008) (77 patients
and 44 controls). The Italian study population included
550 subjects from Central Italy (Italian ancestry): among
them, 199 had a history of testicular maldescent at birth,
whereas 351 were controls. The cryptorchid group
included 132 with unilateral and 67 bilateral cryptorchi-
dism. Also in this case, part of the study population has
been analysed in the previous multicentre study (Nuti
et al., 2008): 159 patients and 275 controls.
Molecular analysis of RXFP2 gene
DNA was extracted from peripheral blood in all the par-
ticipants in this study with the exception of the Italian
controls for whom, depending on sample availability, the
genomic DNA was isolated either from the peripheral
blood or from the frozen semen.
Exon 8 of the RXFP2 gene (RefSeq: NM_130806.3)
containing the T222P variant, was amplified using the fol-
lowing primers: forward: 5¢-GGGGAGGCAGGTTT
TATTTC-3¢; reverse: 5¢-AAGCTAGTGCTAGATGTCATT
GC-3¢. The resulting DNA fragments were analysed by
direct bidirectional sequencing using automated sequencer
(ABI PRISM 3100; Applied Biosystems, Foster City, CA,
USA). For RXFP2 haplotype analysis, a total of five
RXFP2 polymorphisms were analysed in nine carriers of
the T222P mutation. For the analysis of exon 12–intron
12 polymorphisms (exon 12: 957G>A, 993A>G; intron
12: INV12(-2)A9 > A13), the primers were described by
Ferlin et al. (2003). Primers for the intron 7 [INV7(-
351)A>C] and intron 9 polymorphisms [INV9(+380)
A>C] and polymerase chain reaction conditions were
described by Nuti et al. (2008). The resulting DNA frag-
ments were sequenced using automated sequencer (ABI
PRISM 3100; Applied Biosystems).
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Statistical analyses
For statistical analysis of genotype distribution, test for
deviation of Hardy–Weinberg Equilibrium (HWE) or
two-point association studies, we employed tests adapted
from Sasieni (1997). Odds ratio (OR) estimates were
computed from 2 · 2 tables. These calculations were per-
formed on the online resource facility at the Institute for
Human Genetics, Munich, Germany (http://ihg.gsf.de)
and using the Statistical Package for the Social Sciences
software (SPSS, Evanston, IL, USA).
Results
Sequencing analysis of exon 8 of the RXFP2 gene
Spanish study population
The T222P genetic variant was found in both cryptorchid
and control subjects. The variant frequency observed in
the two groups was almost the same; in the cryptorchid
group 3 ⁄ 187 (1.6%), whereas in the controls 7 ⁄ 390
(1.8%).
Italian study population
The variant was significantly more frequent in the patient
group (9 ⁄ 199, 4.5%) than in the control (5 ⁄ 351, 1.4%),
with an OR = 3.17 [95% confidence interval (CI): 1.07–
9.34, p = 0.031]. Data for both study populations are
reported in Table 1.
RXFP2 gene haplotyping
The analysis of five exonic and intronic polymorphisms
allowed the discrimination of different possible haplotypes
on the carriers (Table S1). The analysis of Spanish triplets
(mother, father and son) available for two patients and
of one control ⁄mother pair also indicated that the
T222P is in linkage with the C-C-G-A-13 haplotype
(Fig. 1). In all three carriers, the variant had been trans-
mitted from the father. Patient 08-202 shared with his
father the C-C-G-A-13 haplotype, whereas patient sw09-
9 shared the C-C-G-A-12 allele. In the case of the con-
trol carrier (07-276), only the mother was available for
the analysis and she did not carry the variant. The hap-
lotype in linkage with the variant in this subject is C-
(C ⁄A)-G-(A ⁄G)-13, which potentially includes the C-C-
G-A-13 haplotype.
Table 1 T222P RXFP2 variant in patients with a history of testicular
maldescent and in controls with no history of cryptorchidism








Cryptorchid 3 ⁄ 187a 1.6 0.8 [0.89 (0.2–3.4)]
Unilateral 2 ⁄ 113 1.7
Bilateral 1 ⁄ 74 1.3
Control 7 ⁄ 390a 1.8
Italian
Cryptorchid 9 ⁄ 199 4.5 0.031
[3.17 (1.07–9.34)]Unilateral 5 ⁄ 132 3.7
Bilateral 4 ⁄ 67 5.9
Control 5 ⁄ 351 1.4
aA total of 77 patients and 48 controls from Spain and 159 patients
and 275 controls of Italian origin, from a previous multicentre study
are included (Nuti et al., 2008).
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Figure 1 Haplotype analysis of the three
Spanish families carrying the T222P variant of
the RXFP2 gene. The haplotype linked to the
T222P variant is boxed. In all three carriers,
the variant is inherited from the father.
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Genotype ⁄phenotype correlation
In all 12 cases and 12 controls, the T222P variant was
found in heterozygosity. The phenotypic features of
T222P variant carriers were heterogeneous in both geo-
graphical groups. In fact, the phenotypic expression of
this variant also includes normal testicular descent in 12
cases (7 from Spain and 5 from Italy). This finding
further excludes a causative relationship between the
heterozygous variant and cryptorchidism. The testicular
phenotype of the 12 cryptorchid patients was unilateral
cryptorchidism in seven patients and bilateral cryptorchi-
dism in five. In contrast to a previous study (Ferlin et al.,
2008), the T222P variant was not predominantly present
in persistent bilateral cryptorchid patients. In all cases,
orchidopexy was performed during infancy. Concerning
the three Spanish T222P carriers, whose parents’ DNA
was available, two of them were cryptorchidic (08-202,
sw09-9) and the third one had normal testicular descent
(07-276). In all three subjects, the variant was transmitted
from the father and all of them had normal testes
descent. In the Italian group, DNA from parents was
available only for one carrier, code MMP122 (already
published in Nuti et al., 2008), and in this case, the
variant was transmitted by the mother.
Discussion
The search for clinically relevant genetic factors involved
in non-syndromic cryptorchidism has been largely unsuc-
cessful (Giachini et al., 2007; Foresta et al., 2008). Para-
doxically, not even the strongest candidate genes such as
INSL3 ⁄RXFP2 appear to be involved in the aetiopathogen-
esis of testicular maldescent. The INSL3 gene has been the
subject of a number of studies in which the entire coding
region has been sequenced (for review, see Foresta et al.,
2008). In contrast, the RXFP2 gene has been sequenced
only in a small number of subjects (approx. 160 patients;
Gorlov et al., 2002). In fact, based on the study by Gorlov
et al. (2002) which reported for the first time the T222P
mutation in exon 8, all subsequent studies have focused
on the screening of this specific variant. More than 4000
subjects from different geographical ⁄ ethnic origin have
been analysed so far (Table 2). After the publication of the
first studies, it became evident that this genetic variant is
prevalent in the Mediterranean area (only two carriers
have been described from Hungary in a later study) and is
completely absent from other geographical areas such as
Northern Europe and Asia. Previous studies suggested
that all (except three) T222P carriers share a common
inferred haplotype: C-C-G-A-13 (Ferlin et al., 2003; El
Houate et al., 2008; Nuti et al., 2008). This finding
leads to the hypothesis about a common ancestor with the
C-C-G-A-13 haplotype in the Mediterranean area. The
haplotype analysis in our study population confirmed the
presence of the common C-C-G-A-13 inferred haplotype
in all (except one) Italian and all Spanish carriers
(Table S1). The analysis of two Spanish triplets (mother,
father and cryptorchid son) and a mother ⁄ son pair also
supported the hypothesis of a linkage between the T222P
variant and the C-C-G-A-13 haplotype in these cases: in
one case, the variant is on the C-C-G-A-13 haplotype,
whereas in the other, it is on the C-C-G-A-12 haplotype.
The latter may also derive from the common C-C-G-A-13
through the contraction of the polyadenine stretch. Con-
traction and expansion of repeated sequences is a com-
mon phenomenon. In the control carrier, the markers are
less informative (C-A ⁄C-G-A ⁄G-13) because of the non-
availability of the DNA from the father. However, in this
subject also, the T222P variant can be potentially linked to
the C-C-G-A-13 haplotype.
Table 2 The results of T222P analyses published in the literature in
cryptorchid patients and controls from different countries




France 20 1 (5) 1
United States 13a 0 (0) 3
Mixed origin 41 1
Finland 23 0 (0) 2
Italy (Northern Italy) 1198 29 (2.4) 4, 5, 9
Italy (Central Italy) 199b 9 (4.5) 7
Hungary 70 2 (2.8) 7, cs
Japan 62 0 (0) 6
Morocco 109 3 (2.7) 8
Egypt 53 3 (5.6) 7
Spain 187b 3 (1.6) 7, cs
Control
France 62 0 (0) 1
United States 31 0 (0) 1, 3
Finland 33 0 (0) 2
Italy (Northern Italy) 850 0 (0) 4, 5, 9
Italy (Central Italy) 351b 5 (1.4) 7, cs
Hungary 140 1 (0.7) 7
Germany 100 0 (0) 1
Japan 60 0 (0) 6
Morocco 250 4 (1.6) 8
Spain 390b 7 (1.8) 7, cs
aPatients with familial cryptorchidism.
bIncludes 77 patients and 48 controls from Spain and 159 patients
and 275 controls of Italian origin, from a previous multicentre study
(Nuti et al., 2008).
Current study population is shown in bold; cs, current study.
References: 1, Gorlov et al., (2002); 2, Roh et al., (2003); 3, Feng
et al., (2004); 4, Ferlin et al. (2003); 5, Bogatcheva et al., (2007); 6,
Yamazawa et al., (2007); 7, Nuti et al., (2008); ; 8, El Houate et al.,
(2008); 9, Ferlin et al., (2008).
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These data clearly indicate that a founder effect seems
to be the most plausible explanation for the geographical
restriction of this variant and both Italian and Spanish
carriers probably descend from a common ancestor.
Our results further support the relatively high incidence
of T222P variant in the two Mediterranean countries.
However, although in Spain the frequencies are similar in
cases and controls, in Italy, the T222P variant appears to
be a mild risk factor for crytorchidism. This later finding
contradicts our previous conclusion on the Italian popu-
lation (Nuti et al., 2008) in which a higher but statisti-
cally non-significant (p = 0.054) difference in mutation
frequencies was observed between cases and controls. The
enlarged sample size allowed us to ascertain that this vari-
ant, although not causative, can be considered as a mild
genetic susceptibility factor to cryptorchidism in Italy
(OR = 3.17; 95% CI: 1.07–9.34). Similar to the Spanish
population, a lack of association between the T222P vari-
ant and cryptorchidism has also been reported in another
Mediterranean country, Morocco, where the frequency
of T222P was 2.7% in patients and 1.6% in controls
(El Houate et al., 2007).
The T222P variant has been transmitted by the father
in the three Spanish subjects and this is in contrast to
data from Italy. In fact, both in Central and Northern
Italy, the variant has been transmitted by the mother in
all 10 triplets tested (Bogatcheva et al., 2007; Nuti et al.,
2008). Interestingly, also in Morocco, in two of three
families, a paternal transmission of the variant was
reported (El Houate et al., 2007). All carrier fathers had
normal testis descent.
The observed marked geographical differences in allelic
frequencies make it very difficult to combine data from
different geographical areas. Even a meta-analysis
restricted to the Italian studies is biased by the fact that
in the Northern Italian studies, the T222P variant was
absent in 850 controls, whereas in Central Italy, the
frequency reached 1.4%. This controversy cannot be
explained by differences in the methodology (both labora-
tories used direct sequencing) or in the selection criteria
of controls (with the exception of 300 newborn subjects
included as controls in the study of Ferlin et al. (2008);
therefore, it remains an unsolved paradox. According to
Ferlin et al. (2008), no cases with T222P variant (all het-
erozygous) showed spontaneous descent of the testis and
were reported exclusively in association with bilateral
cryptorchidism. The observed 7 unilateral carriers and 12
controls in our study population are in sharp contrast to
this finding and strongly argue against considering the
T222P variant as a pathogenic mutation with clear-cut
cause–effect relationship with cryptorchidism.
The highly variable phenotypic expression in heterozy-
gous carriers may reflect the presence of other genetic or
environmental factors acting in combination with the
T222P variant. Animal models indicate that the pheno-
typic manifestation of Insl3 ⁄Rxfp2 knockout alleles is sus-
ceptible to genetic background with noted delay in testis
descent in heterozygotes described in one report of an
Insl3 mutant (Nef & Parada, 1999), but not in another
Insl3 mutant (Zimmermann et al., 1999) and in the Rxfp2
(Gorlov et al., 2002). Different environmental conditions,
especially exposure to xeno-oestrogens, may also influence
the phenotypic expression of heterozygote carriers. In this
regard, it has been shown that exposure to mono-N-butyl
phthalate, an endocrine disruptor with weak oestrogenic
activities, impairs Insl3 gene expression and affects testic-
ular descent in rats (Wilson et al., 2004; Shono et al.,
2005). Only heterozygous carriers have been identified so
far; it remains therefore an open question whether homo-
zygosity is strictly associated with cryptorchidism also in
humans.
The different scenario in the two countries may be
related to the accumulation of different genetic or envi-
ronmental modifiers leading to a more mild or wild-type
phenotype in heterozygotes of Spanish descent and to a
more frequently observed pathological condition in Italy.
This hypothesis is supported by a recent study which pro-
vides evidence about relevant genetic differences between
populations belonging to different geographical areas
within Europe (Novembre et al., 2008).
As cryptorchidism is a significant risk factor for
impaired sperm production and testis cancer, the identifi-
cation of transmissible genetic factors is of considerable
interest. We provide evidence that the T222P variant does
not have any pathogenic effect on cryptorchidism in the
Spanish population. Although in Italy it seems to confer a
mild risk to cryptorchidism, the screening for this variant
for diagnostic purposes is not indicated because of the
relatively high frequency of control carriers (1.4% of
Italian men without a history of cryptorchidism).
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